Literature DB >> 23050106

Circulating tumor cells in non-small cell lung carcinoma.

Rogier Boshuizen1, Peter Kuhn, Michel van den Heuvel.   

Abstract

Circulating tumor cells (CTCs) are associated with survival of cancer patients. Several methods have been developed to detect circulating tumor cells. The number of CTCs in NSCLC is lower than in other solid tumors. To date, trials are ongoing for a better understanding of CTCs. Besides association with prognosis, CTCs can be used to assess the efficacy of treatment and they are important substrates for molecular profiling of the tumor..

Entities:  

Keywords:  CTC; CellSearch; HD-CTC; ISET; NSCLC; circulating tumor cells

Year:  2012        PMID： 23050106      PMCID： PMC3461060          DOI： 10.3978/j.issn.2072-1439.2012.08.21

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  21 in total

1.  Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors.

Authors:  Edward H Cho; Marco Wendel; Madelyn Luttgen; Craig Yoshioka; Dena Marrinucci; Daniel Lazar; Ethan Schram; Jorge Nieva; Lyudmila Bazhenova; Alison Morgan; Andrew H Ko; W Michael Korn; Anand Kolatkar; Kelly Bethel; Peter Kuhn
Journal:  Phys Biol       Date:  2012-02-03       Impact factor: 2.583

2.  Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers.

Authors:  Dena Marrinucci; Kelly Bethel; Anand Kolatkar; Madelyn S Luttgen; Michael Malchiodi; Franziska Baehring; Katharina Voigt; Daniel Lazar; Jorge Nieva; Lyudmila Bazhenova; Andrew H Ko; W Michael Korn; Ethan Schram; Michael Coward; Xing Yang; Thomas Metzner; Rachelle Lamy; Meghana Honnatti; Craig Yoshioka; Joshua Kunken; Yelena Petrova; Devin Sok; David Nelson; Peter Kuhn
Journal:  Phys Biol       Date:  2012-02-03       Impact factor: 2.583

3.  Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.

Authors:  Marco Wendel; Lyudmila Bazhenova; Rogier Boshuizen; Anand Kolatkar; Meghana Honnatti; Edward H Cho; Dena Marrinucci; Ajay Sandhu; Anthony Perricone; Patricia Thistlethwaite; Kelly Bethel; Jorge Nieva; Michel van den Heuvel; Peter Kuhn
Journal:  Phys Biol       Date:  2012-02-03       Impact factor: 2.583

4.  Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis.

Authors:  L A Devriese; A J Bosma; M M van de Heuvel; W Heemsbergen; E E Voest; J H M Schellens
Journal:  Lung Cancer       Date:  2011-08-04       Impact factor: 5.705

5.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

6.  Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.

Authors:  Matthew G Krebs; Jian-Mei Hou; Robert Sloane; Lee Lancashire; Lynsey Priest; Daisuke Nonaka; Tim H Ward; Alison Backen; Glen Clack; Andrew Hughes; Malcolm Ranson; Fiona H Blackhall; Caroline Dive
Journal:  J Thorac Oncol       Date:  2012-02       Impact factor: 15.609

7.  18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer.

Authors:  Ugo De Giorgi; Michal Mego; Eric M Rohren; Ping Liu; Beverly C Handy; James M Reuben; Homer A Macapinlac; Gabriel N Hortobagyi; Massimo Cristofanilli; Naoto T Ueno
Journal:  J Nucl Med       Date:  2010-07-21       Impact factor: 10.057

8.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Authors:  Massimo Cristofanilli; G Thomas Budd; Matthew J Ellis; Alison Stopeck; Jeri Matera; M Craig Miller; James M Reuben; Gerald V Doyle; W Jeffrey Allard; Leon W M M Terstappen; Daniel F Hayes
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

Review 9.  Clinical relevance and biology of circulating tumor cells.

Authors:  Natalia Bednarz-Knoll; Catherine Alix-Panabières; Klaus Pantel
Journal:  Breast Cancer Res       Date:  2011-11-01       Impact factor: 6.466

10.  Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer.

Authors:  M Craig Miller; Gerald V Doyle; Leon W M M Terstappen
Journal:  J Oncol       Date:  2009-12-09       Impact factor: 4.375
View more
  5 in total

Review 1.  Screening for lung cancer.

Authors:  Renée Manser; Anne Lethaby; Louis B Irving; Christine Stone; Graham Byrnes; Michael J Abramson; Don Campbell
Journal:  Cochrane Database Syst Rev       Date:  2013-06-21

2.  Classification of large circulating tumor cells isolated with ultra-high throughput microfluidic Vortex technology.

Authors:  James Che; Victor Yu; Manjima Dhar; Corinne Renier; Melissa Matsumoto; Kyra Heirich; Edward B Garon; Jonathan Goldman; Jianyu Rao; George W Sledge; Mark D Pegram; Shruti Sheth; Stefanie S Jeffrey; Rajan P Kulkarni; Elodie Sollier; Dino Di Carlo
Journal:  Oncotarget       Date:  2016-03-15

3.  Microfluidic enrichment for the single cell analysis of circulating tumor cells.

Authors:  Trifanny Yeo; Swee Jin Tan; Chew Leng Lim; Dawn Ping Xi Lau; Yong Wei Chua; Sai Sakktee Krisna; Gopal Iyer; Gek San Tan; Tony Kiat Hon Lim; Daniel S W Tan; Wan-Teck Lim; Chwee Teck Lim
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

4.  Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization.

Authors:  Shannon L Werner; Ryon P Graf; Mark Landers; David T Valenta; Matthew Schroeder; Stephanie B Greene; Natalee Bales; Ryan Dittamore; Dena Marrinucci
Journal:  J Circ Biomark       Date:  2015-05-05

5.  Short-Term Ex Vivo Culture of CTCs from Advance Breast Cancer Patients: Clinical Implications.

Authors:  Nuria Carmona-Ule; Miriam González-Conde; Carmen Abuín; Juan F Cueva; Patricia Palacios; Rafael López-López; Clotilde Costa; Ana Belén Dávila-Ibáñez
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.